• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INGEVITY+; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INGEVITY+; IMPLANTABLE LEAD Back to Search Results
Model Number 7841
Device Problems Failure to Capture (1081); Mechanical Problem (1384); Device Dislodged or Dislocated (2923); Device Contamination with Chemical or Other Material (2944)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/26/2023
Event Type  Injury  
Event Description
It was reported that this right ventricular (rv) lead presented a lack of capture due to it getting dislodged approximately one week after it was implanted.The dislodgment was confirmed with x-ray imaging and fluoroscopy.The device was explanted and when examined, its helix was found to have problems retracting with some tissue found on it.A new device was implanted.No additional patient effects were reported.
 
Event Description
It was reported that this right ventricular (rv) lead presented a lack of capture due to it getting dislodged approximately one week after it was implanted.The dislodgment was confirmed with x-ray imaging and fluoroscopy.The device was explanted and when examined, its helix was found to have problems retracting with some tissue found on it.A new device was implanted.The device has been returned and was analyzed.No additional patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.Testing was completed to assess lead electrical performance and inner.Measurements throughout these tests were within normal limits.Microscopic inspections of the terminal pin assembly, lead body, and electrode tip found no anomalies.Laboratory testing was unable to reproduce the reported clinical observations and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INGEVITY+
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16407925
MDR Text Key309868811
Report Number2124215-2023-07889
Device Sequence Number1
Product Code NVN
UDI-Device Identifier00802526604577
UDI-Public00802526604577
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150012/S083
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number7841
Device Catalogue Number7841
Device Lot Number1238153
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/04/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age86 YR
Patient SexFemale
-
-